Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Chronic Hepatitis B Market Report 2024

Chronic Hepatitis B Global Market Report 2024 – By Drug Class (Antivirals, Immune Modulators), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers) – Market Size, Trends, And Global Forecast 2024-2033

Chronic Hepatitis B Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : August 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Global Chronic Hepatitis B Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Chronic Hepatitis B Market Definition

Chronic hepatitis B is a long-term infection with the hepatitis B virus (HBV) lasting over six months, potentially leading to severe liver damage, liver failure, or liver cancer. It is often asymptomatic for years but can be detected through blood tests and managed with antiviral medications and regular monitoring.

The main types of drugs in chronic hepatitis B include antivirals and immunomodulators. Antivirals are medications designed to inhibit the growth and replication of viruses and help manage the chronic hepatitis B condition by reducing the viral load in the liver and slowing liver damage progression. The gender types include male and female, and the distribution channels include hospital pharmacies, drug stores and retail pharmacies, and online providers.

Chronic Hepatitis B Market Segmentation

The chronic hepatitis b market covered in this report is segmented –

1) By Drug Class: Antivirals, Immune Modulators

2) By Gender: Male, Female

3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

Global Chronic Hepatitis B Market Size 2023 to 2028: Graph

Chronic Hepatitis B Market Size 2024 And Growth Rate

The chronic hepatitis B market size has grown steadily in recent years. It will grow from $3.62 billion in 2023 to $3.77 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to advances in antiviral therapy, growing government and NGO initiatives, improved diagnostic techniques, the rising prevalence of HIV, and increasing awareness.

Chronic Hepatitis B Market Growth Forecast

The chronic hepatitis B market size is expected to see steady growth in the next few years. It will grow to $4.47 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to expansion in emerging markets, growing government policies and funding, improved diagnostics and screening, rising healthcare expenditure, increasing strategic collaborations and partnerships, a growing aging population, and growing public awareness campaigns. Major trends in the forecast period include a shift towards curative therapies, expansion in emerging markets, enhanced diagnostics and screening, partnerships and collaborations, and a and a focus on patient-centric care.

Book your 30 minutes free consultation with our research experts

Contact Us

Chronic Hepatitis B Market Driver: High Prevalence Of Hepatitis B Infection

The high prevalence of chronic hepatitis B infection is expected to propel the growth of the chronic hepatitis B virus market going forward. Hepatitis B is a liver infection brought on by the hepatitis B virus (HBV), which is prevented through vaccination. The increase in hepatitis B infection rates is due to a combination of factors, particularly in low- and middle-income countries, due to low vaccination coverage leading to higher transmission rates as large portions of the population remain unprotected. Rising hepatitis B infection rates can increase demand for diagnostic tests and treatment options. For instance, in December 2022, according to the European Centre for Disease Prevention and Control, a Sweden-based agency for strengthening Europe's defenses against infectious diseases, hepatitis B virus (HBV) infection was recorded in 16,187 cases in 30 Eastern European Member States in 2021. Further, the total cases 15,380 equal a crude rate of 4.7 cases per 100,000 people, compared to 14,332 in 2020. Therefore, the high prevalence of hepatitis B infection will drive the chronic hepatitis B virus market.

Global Chronic Hepatitis B Market Major Players

Major companies operating in the chronic hepatitis b market are Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co Inc, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd., Accord Healthcare Inc, Par Pharmaceutical Inc, Arrowhead Pharmaceuticals Inc, ViiV Healthcare, Arbutus Biopharma Corporation, Ascentage Pharma, ENYO Pharma, Zydus Pharmaceuticals Inc, Nucorion Pharmaceuticals

Global Chronic Hepatitis B Market Trend: Strategic Partnerships In The Chronic Hepatitis B Market

Major companies operating in the chronic hepatitis B market are adopting a strategic partnership approach to enhance their technological capabilities and market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations combining their resources, expertise, and efforts to achieve common goals or objectives. For instance, in January 2021, Gilead Sciences Inc., a US-based biopharmaceutical company, collaborated with VIR Biotechnology, a U.S.-based biotech company, to explore novel combination therapies to achieve a functional cure for chronic hepatitis B virus (HBV). They will commence a Phase 2 trial assessing various combinations of Gilead’s investigational TLR-8 agonist, selgantolimod, Vir’s investigational siRNA, VIR-2218, and a commercially available PD-1 antagonist. Additionally, treatment-experienced patients may receive Gilead’s Vemlidy (tenofovir alafenamide fumarate, TAF). The trial’s primary goal is determining the percentage of patients achieving a functional cure, characterized by the off-therapy disappearance of hepatitis B surface antigen (HBsAg) and HBV DNA from the serum.

Chronic Hepatitis B Market Merger And Acquisition: GSK Acquires Exclusive Rights to Janssen’s Hepatitis B Therapy to Expand Chronic Hepatitis B Portfolio

In November 2023, GSK plc, a U.K.-based pharmaceuticals company, acquired exclusive rights to hepatitis B therapy from Janssen Pharmaceuticals for $1 billion. With the rights to JNJ-3989 (also known as ARO-HBV), an antisense oligonucleotide drug, GSK aims to expand its portfolio and strengthen its position in the treatment of chronic hepatitis B by adding a new, potentially valuable therapy to its offerings. Janssen Pharmaceuticals, a Belgium-based subsidiary of Johnson & Johnson, specializes in developing treatments for various serious and complex diseases, including infectious diseases such as chronic hepatitis B.

Regional Insights For The Global Chronic Hepatitis B Market

North America was the largest region in the chronic hepatitis B market in 2023. The regions covered in the chronic hepatitis b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic hepatitis b market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic hepatitis B market consists of revenues earned by entities by providing services such as diagnostic testing, treatments, liver function monitoring, patient education, and support programs.The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic hepatitis B market also includes sales of medications, interferons, liver transplant medications, diagnostic kits, liver biopsy equipment, and HBV vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chronic hepatitis B market research report is one of a series of new reports from the business research company that provides chronic hepatitis B market statistics, including chronic hepatitis B industry global market size, regional shares, competitors with an chronic hepatitis B market share, detailed chronic hepatitis B market segments, market trends and opportunities, and any further data you may need to thrive in the chronic hepatitis B industry. This chronic hepatitis B market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chronic Hepatitis B Market Report Forecast and Analysis
Report AttributeDetails
Market Size Value In 2024 $3.77 billion
Revenue Forecast In 2033 $4.47 billion
Growth Rate CAGR of 4.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Antivirals, Immune Modulators
2) By Gender: Male, Female
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co Inc, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd., Accord Healthcare Inc, Par Pharmaceutical Inc, Arrowhead Pharmaceuticals Inc, ViiV Healthcare, Arbutus Biopharma Corporation, Ascentage Pharma, ENYO Pharma, Zydus Pharmaceuticals Inc, Nucorion Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Chronic Hepatitis B Market Characteristics

    3. Chronic Hepatitis B Market Trends And Strategies

    4. Chronic Hepatitis B Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Chronic Hepatitis B Market Size and Growth

    5.1. Global Chronic Hepatitis B Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Chronic Hepatitis B Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Chronic Hepatitis B Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Chronic Hepatitis B Market Segmentation

    6.1. Global Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Antivirals

    Immune Modulators

    6.2. Global Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Male

    Female

    6.3. Global Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Drug Stores And Retail Pharmacies

    Online Providers

    7. Chronic Hepatitis B Market Regional And Country Analysis

    7.1. Global Chronic Hepatitis B Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Chronic Hepatitis B Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Chronic Hepatitis B Market

    8.1. Asia-Pacific Chronic Hepatitis B Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Chronic Hepatitis B Market

    9.1. China Chronic Hepatitis B Market Overview

    9.2. China Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Chronic Hepatitis B Market

    10.1. India Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Chronic Hepatitis B Market

    11.1. Japan Chronic Hepatitis B Market Overview

    11.2. Japan Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Chronic Hepatitis B Market

    12.1. Australia Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Chronic Hepatitis B Market

    13.1. Indonesia Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Chronic Hepatitis B Market

    14.1. South Korea Chronic Hepatitis B Market Overview

    14.2. South Korea Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Chronic Hepatitis B Market

    15.1. Western Europe Chronic Hepatitis B Market Overview

    15.2. Western Europe Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Chronic Hepatitis B Market

    16.1. UK Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Chronic Hepatitis B Market

    17.1. Germany Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Chronic Hepatitis B Market

    18.1. France Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Chronic Hepatitis B Market

    19.1. Italy Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Chronic Hepatitis B Market

    20.1. Spain Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Chronic Hepatitis B Market

    21.1. Eastern Europe Chronic Hepatitis B Market Overview

    21.2. Eastern Europe Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Chronic Hepatitis B Market

    22.1. Russia Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Chronic Hepatitis B Market

    23.1. North America Chronic Hepatitis B Market Overview

    23.2. North America Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Chronic Hepatitis B Market

    24.1. USA Chronic Hepatitis B Market Overview

    24.2. USA Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Chronic Hepatitis B Market

    25.1. Canada Chronic Hepatitis B Market Overview

    25.2. Canada Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Chronic Hepatitis B Market

    26.1. South America Chronic Hepatitis B Market Overview

    26.2. South America Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Chronic Hepatitis B Market

    27.1. Brazil Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Chronic Hepatitis B Market

    28.1. Middle East Chronic Hepatitis B Market Overview

    28.2. Middle East Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Chronic Hepatitis B Market

    29.1. Africa Chronic Hepatitis B Market Overview

    29.2. Africa Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Chronic Hepatitis B Market Competitive Landscape And Company Profiles

    30.1. Chronic Hepatitis B Market Competitive Landscape

    30.2. Chronic Hepatitis B Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. F Hoffmann-La Roche Ltd

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck & Co Inc

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Bristol-Myers Squibb Company

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Novartis AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Chronic Hepatitis B Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline plc

    31.2. Dynavax Technologies Corporation

    31.3. Gilead Sciences Inc

    31.4. Viatris Inc.

    31.5. Teva Pharmaceutical Industries Limited

    31.6. Sun Pharmaceutical Industries Ltd.

    31.7. Aurobindo Pharma Limited

    31.8. Dr. Reddy's Laboratories Ltd.

    31.9. Apotex Corp

    31.10. Cipla Ltd

    31.11. Hikma Pharmaceuticals

    31.12. Lupin Pharmaceuticals Inc

    31.13. Vir Biotechnology Inc

    31.14. VBI Vaccines Inc

    31.15. Shenzhen Hepalink Pharmaceutical Co. Ltd.

    32. Global Chronic Hepatitis B Market Competitive Benchmarking

    33. Global Chronic Hepatitis B Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Chronic Hepatitis B Market

    35. Chronic Hepatitis B Market Future Outlook and Potential Analysis

    35.1 Chronic Hepatitis B Market In 2028 - Countries Offering Most New Opportunities

    35.2 Chronic Hepatitis B Market In 2028 - Segments Offering Most New Opportunities

    35.3 Chronic Hepatitis B Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Chronic Hepatitis B Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Chronic Hepatitis B Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: F Hoffmann-La Roche Ltd Financial Performance
  • Table 76: Merck & Co Inc Financial Performance
  • Table 77: Bristol-Myers Squibb Company Financial Performance
  • Table 78: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Chronic Hepatitis B Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Chronic Hepatitis B Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Chronic Hepatitis B Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Chronic Hepatitis B Market, Segmentation By Gender, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Chronic Hepatitis B Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: F Hoffmann-La Roche Ltd Financial Performance
  • Figure 76: Merck & Co Inc Financial Performance
  • Figure 77: Bristol-Myers Squibb Company Financial Performance
  • Figure 78: Novartis AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

Chronic Disease Management Global Market Report 2024 – By Service (Consulting Service, Implementation Service, Educational Service), By Delivery Mode (On-premise, Cloud-based, Web-based), By Disease Type (Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders), By End User (Providers, Payers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chronic Lower Back Pain Global Market Report 2024 – By Type of Pain (Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain), By Diagnosis (Clinical History, Physical Examination, Imaging Guidelines, Assessment of Pain), By End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024 – By Drug Class (Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Other Drug Classes), By Type (Chronic Bronchitis, Emphysema), By End-User (Hospitals, Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chronic Lymphocytic Leukemia Treatment Global Market Report 2024 – By Type (Aggressive CLL, Indolent CLL, Other Types), By Treatment (Targeted Drug Therapy, Chemotherapy, Bone Marrow Transplant, Immunotherapy), By Route of Administration (Oral, Parental, Other Route of Administration), By End-Users (Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chronic Kidney Disease Global Market Report 2024 – By Diagnosis (Blood Test, Urine Test, Imaging Test, Kidney Biopsy), By Treatment (Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments), By Route of Administration (Oral, Intravenous, Subcutaneous), By End-User (Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chronic Pain Global Market Report 2024 – By Product (Drug, Devices ), By Indication (Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications), By End User (Hospitals, Clinics, Research Organization) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2024 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Drug Type (Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types), By Application (Hospitals, Clinic, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chronic Cough Global Market Report 2024 – By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes), By Route Of Administration (Oral, Inhalational, Injectable, Other Route of Administrations), By End-Users (Hospitals, Homecare, Specialty Centers, Other End Users), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the chronic hepatitis b market?

Chronic hepatitis B is a long-term infection with the hepatitis B virus (HBV) lasting over six months, potentially leading to severe liver damage, liver failure, or liver cancer. It is often asymptomatic for years but can be detected through blood tests and managed with antiviral medications and regular monitoring. For further insights on the chronic hepatitis b market, request a sample here

How will the chronic hepatitis b market drivers and restraints affect the chronic hepatitis b market dynamics? What forces will shape the chronic hepatitis b industry going forward?

The chronic hepatitis b market major growth driver - High Prevalence Of Hepatitis B Infection. For further insights on the chronic hepatitis b market, request a sample here

What is the forecast market size or the forecast market value of the chronic hepatitis b market?

The chronic hepatitis B market size has grown steadily in recent years. It will grow from $3.62 billion in 2023 to $3.77 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to advances in antiviral therapy, growing government and NGO initiatives, improved diagnostic techniques, the rising prevalence of HIV, and increasing awareness. The chronic hepatitis B market size is expected to see steady growth in the next few years. It will grow to $4.47 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to expansion in emerging markets, growing government policies and funding, improved diagnostics and screening, rising healthcare expenditure, increasing strategic collaborations and partnerships, a growing aging population, and growing public awareness campaigns. Major trends in the forecast period include a shift towards curative therapies, expansion in emerging markets, enhanced diagnostics and screening, partnerships and collaborations, and a and a focus on patient-centric care. For further insights on the chronic hepatitis b market, request a sample here

How is the chronic hepatitis b market segmented?

The chronic hepatitis b market is segmented
1) By Drug Class: Antivirals, Immune Modulators
2) By Gender: Male, Female
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online ProvidersFor further insights on the chronic hepatitis b market, request a sample here

Which region has the largest share of the chronic hepatitis b market? What are the other regions covered in the report?

North America was the largest region in the chronic hepatitis B market in 2023. The regions covered in the chronic hepatitis b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the chronic hepatitis b market, request a sample here.

Who are the major players in the chronic hepatitis b market?

Major companies operating in the chronic hepatitis b market are Pfizer Inc., F Hoffmann-La Roche Ltd, Merck & Co Inc, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Dynavax Technologies Corporation, Gilead Sciences Inc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Apotex Corp, Cipla Ltd, Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc, Vir Biotechnology Inc, VBI Vaccines Inc, Shenzhen Hepalink Pharmaceutical Co. Ltd., Accord Healthcare Inc, Par Pharmaceutical Inc, Arrowhead Pharmaceuticals Inc, ViiV Healthcare, Arbutus Biopharma Corporation, Ascentage Pharma, ENYO Pharma, Zydus Pharmaceuticals Inc, Nucorion Pharmaceuticals For further insights on the chronic hepatitis b market, request a sample here.

What are the key trends in the chronic hepatitis b market?

Major trend in the chronic hepatitis b market - Strategic Partnerships In The Chronic Hepatitis B Market. For further insights on the chronic hepatitis b market, request a sample here.

What are the major opportunities in the chronic hepatitis b market? What are the strategies for the chronic hepatitis b market?

For detailed insights on the major opportunities and strategies in the chronic hepatitis b market, request a sample here.

How does the chronic hepatitis b market relate to the overall economy and other similar markets?

For detailed insights on chronic hepatitis b market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the chronic hepatitis b industry?

For detailed insights on the mergers and acquisitions in the chronic hepatitis b industry, request a sample here.

What are the key dynamics influencing the chronic hepatitis b market growth? SWOT analysis of the chronic hepatitis b market.

For detailed insights on the key dynamics influencing the chronic hepatitis b market growth and SWOT analysis of the chronic hepatitis b industry, request a sample here.